In the intricate landscape of the healthcare industry, the discourse surrounding drug pricing frequently fixates on the list price. Public…
Read More
From List Price to Net Price: How Finance Leaders Decode Real Drug Costs
Lungs Identified as a Primary Site of Blood Production in Humans Challenging Decades of Medical Dogma
For more than a century, the medical community has operated under the fundamental assumption that the bone marrow serves as…
Read More
How digital tools and AI are accelerating drug discovery
The pharmaceutical industry stands at a critical juncture, grappling with escalating costs and protracted timelines in the arduous journey of…
Read More
How Clinical Laboratories Can Prepare for Crisis Events Before They Happen
Clinical laboratories, the silent sentinels of public health, operate at the nexus of patient care and scientific precision. Yet, this…
Read More
Novartis to Acquire Excellergy for Up to $2 Billion to Bolster Next-Generation Anti-IgE Allergy Pipeline
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More
New Recommendations Prioritize Proactive Cholesterol Management for Long-Term Heart Disease Prevention
New heart health recommendations emphasize early testing and treatment to lower cholesterol levels as key to reducing the risk of…
Read More
Galahadcorvus rhysi: A Swift, Land-Dwelling Predator Emerges from the Triassic of Gloucester
The ancient landscape of what is now Gloucester, United Kingdom, has yielded a remarkable secret from approximately 215 million years…
Read More
Yale Researchers Uncover Molecular Mechanism Preventing Fertilization Offering New Paths for Infertility Treatment and Contraception
A multidisciplinary research team led by Yale University has successfully mapped a naturally occurring biological mechanism in mammals that prevents…
Read More
FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design
Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…
Read More
Darzalex Secures Landmark European Approval for Self-Administration in Multiple Myeloma, Ushering in a New Era of Home-Based Cancer Care
Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More